Research Article

Generation and Characterization of Mice Carrying a Conditional Allele of the Wwox Tumor Suppressor Gene

  • John H. Ludes-Meyers,

    Affiliation: Department of Carcinogenesis, University of Texas M.D. Anderson Cancer Center, Science Park-Research Division, Smithville, Texas, United States of America

  • Hyunsuk Kil,

    Affiliation: Department of Carcinogenesis, University of Texas M.D. Anderson Cancer Center, Science Park-Research Division, Smithville, Texas, United States of America

  • Jan Parker-Thornburg,

    Affiliation: Department of Biochemistry and Molecular Biology, University of Texas M.D. Anderson Cancer Center, Houston, Texas, United States of America

  • Donna F. Kusewitt,

    Affiliation: Department of Carcinogenesis, University of Texas M.D. Anderson Cancer Center, Science Park-Research Division, Smithville, Texas, United States of America

  • Mark T. Bedford,

    Affiliation: Department of Carcinogenesis, University of Texas M.D. Anderson Cancer Center, Science Park-Research Division, Smithville, Texas, United States of America

  • C. Marcelo Aldaz mail

    Affiliation: Department of Carcinogenesis, University of Texas M.D. Anderson Cancer Center, Science Park-Research Division, Smithville, Texas, United States of America

  • Published: November 10, 2009
  • DOI: 10.1371/journal.pone.0007775


WWOX, the gene that spans the second most common human chromosomal fragile site, FRA16D, is inactivated in multiple human cancers and behaves as a suppressor of tumor growth. Since we are interested in understanding WWOX function in both normal and cancer tissues we generated mice harboring a conditional Wwox allele by flanking Exon 1 of the Wwox gene with LoxP sites. Wwox knockout (KO) mice were developed by breeding with transgenic mice carrying the Cre-recombinase gene under the control of the adenovirus EIIA promoter. We found that Wwox KO mice suffered from severe metabolic defect(s) resulting in growth retardation and all mice died by 3 wk of age. All Wwox KO mice displayed significant hypocapnia suggesting a state of metabolic acidosis. This finding and the known high expression of Wwox in kidney tubules suggest a role for Wwox in acid/base balance. Importantly, Wwox KO mice displayed histopathological and hematological signs of impaired hematopoeisis, leukopenia, and splenic atrophy. Impaired hematopoeisis can also be a contributing factor to metabolic acidosis and death. Hypoglycemia and hypocalcemia was also observed affecting the KO mice. In addition, bone metabolic defects were evident in Wwox KO mice. Bones were smaller and thinner having reduced bone volume as a consequence of a defect in mineralization. No evidence of spontaneous neoplasia was observed in Wwox KO mice. We have generated a new mouse model to inactivate the Wwox tumor suppressor gene conditionally. This will greatly facilitate the functional analysis of Wwox in adult mice and will allow investigating neoplastic transformation in specific target tissues.


WW domain-containing oxidoreductase (WWOX) was cloned and identified as a potential tumor suppressor gene mapping to the chromosome region 16q23 [1]. The WWOX gene spans >1.1 Mb and overlaps the common chromosomal fragile site, FRA16D, the second most common site for chromosomal breakage, instability and rearrangement of the whole genome [1][3]. Allelic losses and rearrangements affecting the WWOX locus have been described in various human cancers [1][5]. Additionally, various studies have reported significant loss of WWOX expression in multiple human neoplasias including breast, prostate, ovarian, lung and liver cancer [6], [7].

WWOX is a 46-kD protein, highly conserved through evolution, that contains two N-terminal WW-domains and a short chain dehydrogenase/reductase domain (SDR domain) [1]. Our understanding of the NAD(P)(H)-dependent enzymatic functions of WWOX is very limited. WWOX's structure is the archetypal representative of one of four separate clusters of classical SDRs conserved through evolution [8], [9]. Based on the high expression of WWOX in hormonally regulated tissues (testis, prostate and ovary) and its amino acid sequence homology to specific oxidoreductases, we postulated that WWOX maybe an enzyme involved in sex-steroid metabolism [1]. The WW-domains are required for protein-protein interactions through binding the conserved proline-rich sequence PPXY. Several proteins have been identified as WWOX protein partners such as SIMPLE, SCOTIN [10] and EZRIN [11] as well as several transcription factors such as the tumor suppressor p73[12], ERBB4-CTF [13], AP2γ [14], MET-CTF [15] and the osteoblast differentiation master regulator, RUNX2 [16], to name a few. One role for WWOX has emerged as a regulator of transcription by limiting transcription factor access to the nucleus through cytoplasmic sequestration [6].

The role of WWOX as a tumor suppressor is supported by in vitro studies with human cancer cells and in vivo studies using mouse models. Several studies reported that ectopic WWOX expression suppressed the in vivo tumorigenicity of various human tumor types including, breast [5], lung [17], prostate [18] and ovarian [19] cancer cells when xenografted in nude mice. Mouse models with targeted disruption of Wwox had increased spontaneous tumor incidence. Using a conventional mouse knockout approach Aqeilan et al. [20] reported development of osteosarcomas in some Wwox−/− mice by the age of 2.5 weeks and as early as postnatal day 3. All Wwox null mice died by 3–4 wk of age precluding any further studies of adult animals. However, development of spontaneous lung papillary carcinoma was observed in adult Wwox+/− mice. Aqelian et al [20] also reported that Wwox+/− mice treated with chemical carcinogens displayed an increased incidence of lymphomas and lung tumors when compared with wild type littermates. Using a gene trap approach we developed a Wwox hypomorphic mouse model [21]. Female Wwox hypomorphs had an increased incidence of spontaneously arising B-cell lymphomas. In addition, several female developed multiple neoplasias. Together, the in vitro and in vivo studies have provided significant evidence for Wwox as a tumor suppressor.

We are interested in understanding in more detail the normal and tumor suppressive role Wwox plays in the multiple tissues it is expressed. As mentioned, Wwox KO mice generated using conventional techniques die by four weeks of age thus impeding any studies in adult tissues. Therefore, we report here the generation of mice with a conditional allele for Wwox ablation for better understanding the roles of Wwox in different tissues and in pathological conditions.


Generation of Mice with a Floxed-Wwox Allele

We devised a strategy for conditional ablation of Wwox gene expression using the Cre-Lox site-specific recombination system. Our approach, illustrated in Figure 1, utilized positive-negative selection gene targeting [22] to modify Wwox genomic sequences by flanking Wwox Exon 1 with two LoxP-recombination sites to generate a “floxed”-Wwox allele. We successfully targeted mouse ES cells and generated chimeric founders having germline transmission and subsequently bred a Wwoxflox mouse.


Figure 1. Targeting the Mouse Wwox allele.

(A) Insertion of the targeting vector into the Wwox allele introduced a new Bgl II (B) restriction site into Wwox Intron 1. The new Bgl II site leads to a smaller Bgl II restriction fragment when analyzed by Southern blot with the external hybridization probe. Additionally, a Not I restriction site was engineered at the 3′ end of the right arm used to linearize the targeting construct prior to electroporation. (B) Southern blot genotyping of wild-type (wt/wt) mice, heterozygous mice (wt/flox) and homozygous mice (flox/flox). (C) Multiplex-PCR based genotyping using allele specific primers. Primers A and B anneal to Wwox specific sequences in the Wwox upstream regulatory region (primer A) and in Wwox Exon 1 (primer B). Primer C anneals to sequences in the LoxP Cre-recombination in the targeted Wwox allele. Multiplex PCR using primers A, B and C yield DNA products having sizes specific for the wild-type and targeted alleles.


Since it was possible that the inserted pgk-neo plasmid could impair Wwox gene transcription we determined whether the floxed-Wwox allele had any effect on viability and fertility. Breeding of heterozygous (Wwox+/flox) mice from two different founders resulted in pups having genotypes with the expected Mendelian ratios demonstrating that the floxed allele had no effect on embryonic development or viability. Mating of Wwoxflox/flox males with Wwoxflox/flox females resulted in normal litter size, genotype frequencies and pups had normal postnatal development. These results showed that the “floxed”-Wwox allele containing the insertion of the ~2 Kb neomycin resistance gene in the 5′ transcriptional control region of the Wwox gene had no detrimental affect on Wwox functions required for normal mouse growth, survival or reproduction. Therefore, this mouse model will be a useful tool for analyzing Wwox function(s) in specific mouse tissues.

Cre-Recombinase Deletion of the Wwox Gene Completely Ablates Wwox Expression

We showed that our strategy resulted in the specific modification of the Wwox allele resulting in the insertion of the two LoxP-recombination sequences flanking Exon 1 however it is possible that small changes to the inserted sequence could have been introduced during the procedure. Therefore, to determine whether Cre-recombinase could utilize the inserted LoxP sites to delete Wwox Exon 1, we generated mice combining the Wwoxflox allele with the Cre-recombinase gene under the control of the adenovirus EIIA promoter. The adenovirus EIIA promoter directs transcription of Cre-recombinase at the zygote stage of embryonic development resulting in deletion of floxed sequences in all cells of the developing embryo including the germ cells [23]. To determine whether Cre-recombination was successful we analyzed genomic DNA using PCR with oligonucleotide primers specific for wild-type or Cre-deleted Wwox sequences (Figure 2). Using this strategy we were able to test the functionality of the LoxP sites, determine whether our strategy of deleting Exon 1 would eliminate Wwox expression and give rise to a phenotype.


Figure 2. Strategy for Cre-mediated ablation of Wwox expression.

(A) To promote deletion of Wwoxflox alleles we used transgenic mice carrying the Cre-recombinase gene under control of the adenoviral EIIA-promoter. EIIA-regulated Cre-recombinase is expressed in pre-implantation embryos leading to site-specific deletion of LoxP flanked (floxed) sequences in all tissues including germ cells. (B) PCR-based strategy to demonstrate Cre-recombinase deletion of the Wwox target sequences. (C) Wwox protein expression is abolished in Wwox KO mice. Total protein extracts from the indicated tissues were analyzed by immunoblotting using Wwox specific antibodies. Anti-actin was used as a loading control. WT-wild-type, HET-heterozygous, KO-knockout.


We then mated Wwoxflox/flox mice with homozygous EIIA-Cre transgenic mice that resulted in the first familial generation (F1) of pups having one Wwox allele with wild-type sequences and one Wwox allele with Exon 1 deleted (Wwox+/ΔCre). Since the WwoxΔCre allele was present in the germ cells a F1×F1 cross should result in pups having all possible genotypes (Wwox+/+; Wwox+/ΔCre; WwoxΔCre/ΔCre) with Mendelian ratios of 1:2:1 (Table 1). Successful matings from all mating pairs (n = 10) were obtained demonstrating that Wwox+/ΔCre mice were fertile having litter sizes ranging between 3 to 11 pups (average = 7.75). Three-day old pups were genotyped by PCR (Figure 2) and correct Mendelian ratios were obtained after genotyping 154 animals (p = 0.257 using the χ2-test). To demonstrate that our targeting strategy lead to complete ablation of Wwox expression we performed immunoblot analysis of total protein extracts from a variety of tissues (Figure 2). As expected Wwox protein was undetectable in WwoxΔCre/ΔCre mice and was reduced by approximately one-half in heterozygotes confirming that Cre-mediated deletion of Wwox Exon 1 lead to the complete absence of Wwox protein.


Table 1. Genotypes of pups from Wwox+/ΔCre × Wwox+/ΔCre crosses.


Ablation of Wwox expression lead to significant growth retardation that was noticeable at birth (Figure 3A). To further address pup growth we weighed pups periodically and found that Wwox KO mice had a severe growth defect averaging only 4.2 g at postnatal day 14 compared to heterozygous and wild-type mice (6.82 and 7.07 g, respectively). Although some Wwox KO mice can survive up to 3 weeks of age, the mortality rate was very high. As early as 72 h after birth 43% (15 of 35) of Wwox KOs had died and 77% had died by 17 days after birth and no mice survived past weaning. These findings demonstrated that ablation of Wwox expression by deleting Exon 1 using our Cre-loxP strategy lead to growth retardation and postnatal death in agreement with the observations of Aqeilan et al [16], [20] using conventional knockout technology.


Figure 3. Wwox KO mice have reduced postnatal growth.

(A) Photograph of WT and KO newborn littermates. (B) F2 pups were weighed on postnatal days 3, 10, 14 and 17. 100% of Wwox KO mice died before weaning (21 days). WT, n = 18; HET, n = 43; KO, n = 8. Error bars represent ±SEM.


Ablation of Wwox Expression by EIIA-Cre Mediated Deletion Resulted in Impaired Hematopoiesis and Splenic Athrophy

To try to understand the cause of death of Wwox KO mice we performed necropsies and analyzed blood chemistries of mice at postnatal day 18. Necropsy results found significantly reduced relative weights of multiple organs and increased brain weight in KO mice consistent with wasting (Table 2). Interestingly, spleens of KO mice were dramatically reduced in size and weight when compared with those of wild-type and heterozygous. The average Wwox KO spleen weighed 9.3 mg on average, representing 0.21% of whole body weight, while spleens from wild-type and heterozygotes mice weighed on average 4 times as much representing up to 0.53–0.46% of whole body weight, i.e more than 2 fold that relative weight of KO mice (p = 0.0015) (Table 2). The histology of the Wwox KO mice spleens was very abnormal displaying signs of spleen atrophy. As can be observed in Figure 4, the red pulp displayed dramatically reduced cellularity, although hematopoietic cells of all series appear to be present. Lymphoid aggregates of the white pulp of the KO spleens were also reduced in size compared to the WT spleens.


Figure 4. Wwox KO mice have abnormal spleens and thymuses.

Histopathology of spleens (top four panels) and thymuses (bottom four panels) from 18 day old KO and WT mice. Histological sections were stained with H&E. Note the significant atrophy of the spleen and the reduced cortical thickness in the thymus from the KO mice. Low power images of spleens (first row) and thymuses (third row) have a total magnification of 21X. High power images of spleens in (second row) have a total magnification of 84X and thymuses (bottom row) have a total magnification of 44X.


Table 2. Organ Weights.


We also compared the histology of thymus that also displayed reduced relative weight (p = 0.05). We observed that in spite of preserving relatively normal organ architecture, the cortex of the thymus of KO mice is significantly thinner than that of wild type counterparts (Figure 4).

Given these histopathological findings we proceeded to perform some hematological analyses. White blood counts (WBC) were estimated manually on blood smears obtained from mice of the different genotypes. WBC for wild-type mice was estimated at an average of 9.45×103 cells per ul (±2.25, n = 2) while Wwox KO mice showed signs of leukopenia with lower WBC at an average of 4.2×103 cells per ul (±1.20, n = 2). No major differences were observed in the relative representation of the various white blood cell subtypes (not shown). However, one of the two KO mice analyzed displayed 3% of nucleated red blood cells (NRBC)/100 WBCs, a clear sign of severe anemia, while none of the WT mice showed any NRBCs. In summary, the histopathological and hematological findings suggest significantly impaired hematopoiesis in Wwox KO mice affecting white and red blood cell lineages.

Wwox KO Mice Displayed Signs of Metabolic Acidosis and Kidney Failure

Most of the parameters measured by blood chemistry were not significantly different in the Wwox KOs compared with wild-type and heterozygotes (Table 3). However, glucose levels of Wwox KO mice were significantly lower than wild-type and heterozygotes (63% of HET and 57% of WT levels, Table 3). Circulating calcium levels were also significantly lower in KO mice (p = 0.0004). More importantly, Wwox KO animals displayed blood chemistry values compatible with kidney failure since they showed higher blood urea nitrogen (BUN) (two-fold higher, p = 0.01). In addition, KO mice displayed dramatically reduced bicarbonate levels (CO2) in blood (p = 0.006) indicative of serious disturbance in the acid/base balance compatible with metabolic acidosis.


Table 3. Blood Chemistry Analysis.


Wwox is Required for Normal Bone Mineralization

Since the KO mice were markedly smaller in size compared to litter mates and it was previously reported that Wwox KO mice had defects in bone formation [16] we decided to perform bone analyses of our Wwox KO mouse. We used micro-computed tomography (micro-cT) and bone histomorphometry to measure several parameters of endochondral bone formation. Femurs of 18-day old mice were used for these analyses. Micro-cT analyses were used to obtain high-resolution scans and constructed 3-D images to examine morphological features (Figure 5A). We observed a significant decrease in bone volume and cortical thickness in Wwox KO mice compared to WT and HETs. Also, it was evident that cortical porosity and the number of trabeculae were decreased in Wwox KO mice. We also subjected femurs of the same mice to detailed histomorphometric analyses. For these studies sections of femurs were quantified histologically for static parameters of bone formation such as bone volume, trabecular number and cell counts. Sections of femurs stained using Von Kossa that identifies mineralized bone clearly demonstrated a reduction of bone formation in KO mice (Fig. 5B). The most significant difference observed in Wwox KO femurs was in bone volume. Bone volume measurements quantify the volume of mineralized and non-mineralized portions (osteoid) of the tissue. The bone volumes of femurs from KO mice were reduced >66% in comparison to femurs from WT and HET mice (BV/TV %, 13.35% vs. 5.8%, respectively; p<0.01, Fig. 5C). To more clearly define which parameters of bone formation were impaired in KO mice, volumes of mineralized and osteoid tissue were determined. Interestingly, femurs of KO mice were significantly less mineralized compared to WT and HET mice (Md.V/TV %, 13.3% vs. 5.7%, p<0.01, Fig. 5C) and KO mice femurs tended to have more osteoid than WT and HET femurs (OV/BV %, 0.36% vs. 3.5%, p = 0.07). The number and thickness of trabeculae were also reduced in femurs of KO mice (Fig. 5C). This was also observed using micro-cT. This indicates that there was a decrease in bone formation in Wwox KO mice that is likely due to a lack of mineralized tissue.


Figure 5. Histomorphometric analysis.

(A) MicroCT images of femurs from postnatal day 18 mice. Note the dramatic difference in bone structure of the femur from KO mice vs WT and HET mice bones (B) Von Kossa stained sections of femurs from mice of the indicated genotypes. Black stained areas represent mineralized bone tissue. Note the significantly decreased mineralization in the KO mice bone sample (C) Quantitative histomorphometric analyses of postnatal day 18 day mice. We did not observe differences between wild-type and heterozygous mice, therefore, we compared KO data (n = 3) with WT and HET data combined (WT+HET, n = 5). Wild-type-WT, heterozygote-HET, knockout-KO. BV/TV%-bone volume/tissue volume, Md.V/TV%-mineralized volume/tissue volume, Tb.N-Trabecular number (1/mm), Tb.Th-Trabecular thickness (micrometers). *p<0.05.


Therefore, to understand the defect of bone formation in Wwox KO mice we performed histomorphometric measurements of osteoblast and osteoclast activity. Measurements of osteoclast activity did not show any differences in femurs from mice of any genotype. We quantitated osteoblast activity and found that there were no significant differences in the number of active and non-active osteoblasts in femurs from all genotypes. Additionally, osteoblasts of KO mice were healthy, plump, cuboidal cells of normal morphology. However, there was a significant difference in the number of active osteoblasts over bone surface (N. Ob/BS) in femurs of KO mice (p = 0.02). This indicates that osteoblasts of Wwox KO have a defect in mineralization resulting in reduced bone formation.

A total of nine 18d old Wwox KO mice were subjected to complete necropsies, X ray analyses and multiple organ histopathology. We did not observed any lesions compatible with neoplastic growth by any of the methodologies. Importantly, X ray analyses did not reveal any bone lesions compatible with osteosarcoma.


The WWOX tumor suppressor gene is inactivated in many types of human cancers by genomic rearrangements, aberrant mRNA splicing, homozygous deletions and epigenetic silencing [1][5], [24]. Because Wwox KO mice do not survive to adulthood previous studies of Wwox tumor suppression required chemical carcinogen treatment of Wwox+/− mice [20]. Therefore, we have generated mice carrying a conditional allele of the Wwox tumor suppressor gene.

In this report we describe the generation and initial characterization of a novel mouse model with a conditional Wwox allele. We utilized adenovirus EIIA-regulated Cre-recombinase transgenic mice to delete Wwox Exon 1 in all mouse tissues and ultimately generated Wwox KO mice. We found that Wwox KO mice suffered from severe metabolic defect(s) resulting in significant growth retardation, hypoglycemia, impaired hematopoeisis, and signs of metabolic acidosis that ultimately lead to premature death of all mice by 3 weeks of age. Bone formation of Wwox KO was also significantly affected. Bones from KO mice were analyzed and found to be smaller and thinner having reduced bone volume as a consequence of a defect in mineralization.

The results of the blood chemistry analysis demonstrated that Wwox KO mice had severe metabolic defects. Hypoglycemia can result from multiple causes such as disorders in carbohydrate, fat or amino acid metabolism as well as endocrine system disorders. Since Wwox is expressed in a variety of endocrine, neuroendocrine and non-endocrine tissues it is not possible from these studies to identify the cause of hypoglycemia. The combination of increased BUN with reduced bicarbonate levels (hypocapnia) suggests impaired kidney function and a disturbance in the blood acid-base balance that would result in acidosis. Protracted acidosis disturbs many bodily functions and can lead to growth retardation, bone disease, possibly total kidney failure and ultimately death. Renal tubular acidosis (RTA) is a pathology that occurs when the kidneys fail to excrete acids into the urine, which causes the blood to remain too acidic due to defects of cells in the proximal and distal convoluted tubules. The convoluted tubules of healthy kidneys help maintain acid-base balance by excreting acids into the urine and returning bicarbonate to the blood. Interestingly, we have previously demonstrated that Wwox is highly expressed in distal convoluted tubules and to a lesser extent in the proximal tubules of the kidney in mice (Figure 6) and humans [25]. Given the pathology observed and the location of Wwox expression in the kidney we hypothesize that WWOX may play a role in the regulation of blood pH and maintenance of electrolyte balance. Thus, we speculate that the lack of Wwox expression in the kidney tubules in KO mice is likely responsible for the development of severe metabolic acidosis of renal tubule origin (RTA) that ultimately leads to death. In addition, as significant contributing factors to morbidity and death, we also observed severe histopathological abnormalities affecting hematopoietic organs such as spleen and thymus in addition to white blood cell counts compatible with a significant suppression on hematopoiesis affecting the Wwox KO mice. Specifically, the spleens of Wwox KO mice displayed signs of atrophy with dramatic reduction in red pulp cellularity. All studies indicate that Wwox KO mice suffered from anemia and leukopenia. Anemia can be also intimately linked to kidney function and to metabolic acidosis. Additional studies will be required to determine the exact causes of the impaired hematopoiesis observed as a result of Wwox ablation.


Figure 6. Wwox is strongly expressed in the kidney tubules.

Kidneys from a WT (left panel) or a KO (right panel) 18 day old mouse were dissected, paraffin embedded and subjected to immunohistochemical staining using anti-WWOX antibody. The strongest staining structures represent the distal convoluted tubule section of nephrons. Photomicrographs were taken using a 40X objective.


Wwox KO mice have been described to suffer alterations in bone metabolism [16]. We developed this conditional mouse model to facilitate the exploration of the cell autonomous function(s) of Wwox that contribute to the variety of abnormalities we and others have observed. Therefore, we wanted to determine whether our mouse model of EIIA-Cre mediated ablation of Wwox expression recapitulated the observed defects in normal mouse bone development. We used micro-cT and histomorphometry to measure several static bone parameters. We observed a decrease of bone formation in Wwox KO mice associated with a reduction of mineralization and concomitant increase in osteoid compared to WT and HET mice. Proper bone formation results from a fine balance between bone formation and bone resorption. This balance is mostly maintained by the activity of two bone cell types, osteoblasts and osteoclasts, that make bone and degrade bone respectively. We measured osteoblast activity and found no significant differences in the number of active and non-active osteoblasts in femurs between genotypes. Measurements of osteoclast activity did not show any differences in femurs from mice of any genotype either. This is in sharp contrast to the observations of Aqeilan et al [16] who observed consistently higher numbers of osteoclast activity in bone sections of KO mice however they did not perform quantitative analyses in those studies. We conclude that Wwox KO mice have reduced bone formation due to a bone mineralization defect. This is consistent with previous results that demonstrated a significant defect in differentiation of Wwox KO calvarial osteoblasts ex vivo compared to WT osteoblasts [16]. Notably, heterozygous mice did not show any abnormalities in postnatal growth and survival as well as blood or bone parameters highlighting that only one Wwox allele is sufficient for full function.

Importantly, Aqeilan et al. also reported that 4 of 13 (31%) mice Wwox KO mice developed focal lesions along the femoral diaphysis compatible with periostal osteosarcoma, lesions observed in one mice as early as 3d of age [20]. It is worth noting that in contrast with those previous observations, we did not detect any lesions compatible with spontaneous osteosarcomas in any of the Wwox KO mice analyzed macroscopically, histopathologically and radiographically. Furthermore, none of the long bones that were subjected to MicroCT analyses revealed any malignant lesions either. The reason(s) for the discrepancies between studies remain to be determined.

Very recently a spontaneous mutation in the Wwox gene was identified in rats that showed severe growth retardation, experienced epileptic seizures and died without reaching maturity [26]. The mutation, named lde for lethal dwarfism with epilepsy, was identified as a 13-bp deletion in Exon 9 of the Wwox gene resulting in a frame shift mutation causing aberrant amino acid sequences (371–424aa) at the C-terminal of the Wwox protein. Remarkably, lde/lde rats displayed phenotypic characteristics similar to Wwox KO mice including severe dwarfism and early lethality. The cause of dwarfism is not clear, however, lde/lde rats had slightly lower bone density and no osteosarcomas developed during their short life span [27]. Interestingly, lde/lde rats displayed significantly higher levels of BUN compared to normal rats [27] consistent with the blood chemistry of our Wwox KO mice.

In conclusion, we have generated a novel mouse model with a conditional allele at the Wwox locus. We demonstrated that homozygous Cre-recombinase mediated deletion of Wwox Exon 1 lead to complete ablation of Wwox expression. Loss of Wwox expression by this approach resulted in a phenotype similar to the previously reported Wwox KO generated by conventional techniques making this Wwoxflox strain an important reagent for studying Wwox function in normal mouse physiology and tissue specific tumorigenesis.

Materials and Methods

Animal Husbandry

Mice used in this were kept in a clean, modified-barrier animal facility, fed regular commercial mouse diet (Harlan Lab., Indianapolis, IN) under controlled light (12L:12D) and temperature (68–74°F). All animal research was conducted in facilities accredited by the Association for Assessment and Accreditation of Laboratory Animal Care International (AAALAC) at the University of Texas, M.D. Anderson Cancer Center, Science Park Research Division, following international guidelines and all research was approved by the corresponding Institutional bioethics committee (IACUC).

Gene Targeting and Generation of a Wwox-Floxed Allele

The Wwox targeting construct was generated using ~6 Kb of Wwox gene obtained from BAC clone 9N99 containing a 5′ portion of the Wwox gene from 129/svJ mouse genomic DNA. Primers used for generating the targeting construct were: Right arm forward, 5′-CAAAACCCGGAAACTGGATTACAGC-3′;

Right arm reverse, 5′-CCTAGACTGTGCTGCTCCAA-3′; Left arm forward, 5′-GAGGAGGAGGAGGAGGGAAGTAGAGG-3′; Left arm reverse, 5′-CAGCTACTGGCGGGAAAGGG-3′. First, a ~4 Kb genomic sequence containing Wwox Exon1 and a portion of Intron 1 was PCR amplified and cloned into plasmid pK-11 [28]. pK-11 contains the neomycin transferase gene under control of the phosphoglycerol kinase promoter (pgk-neo) used as the positive-selection element and a single LoxP Cre-recombinase recognition site. Another LoxP Cre-recombinase recognition site was inserted into Wwox Intron 1 in the same orientation as the pK-11 LoxP site in order to “flox” Wwox Exon 1 (Wwoxflox) resulting in the plasmid pK-11-Wwox-flox. The left arm of the targeting construct was generated by cloning ~2 Kb of the Wwox 5′ upstream sequence into the plasmid pBJ101-DT [22]. Plasmid pBJ101-DT contains the diphteria toxin A-chain gene (DT-A) used as the negative-selection element. The final targeting construct was generated by transferring the DT-A gene and Wwox left arm sequences to pK-11-Wwox-flox plasmid (Figure 1A).

The Wwox target construct was then used by the UT MD Anderson Genetically Engineered Mouse Facility (GEMF) for generation of targeted ES cells and mouse chimeras. ES cell clones were electroporated with the Wwox targeting vector that had been linearized by digestion with Not I restriction endonuclease. Transfected ES cells were selected for G418-resistance and individual clones screened by Southern hybridization. Genomic DNA was digested with Bgl II and hybridized to a probe corresponding to a region of Wwox Intron 1 outside of the targeting construct sequences (Figure 1A). Correctly targeted ES cells were identified by hybridization to two Bgl II restriction fragments of ~9 Kb and ~4 Kb representing the Wwox+ and Wwoxflox alleles, respectively (Figure 1A,B). The hybridization probe was generated by PCR amplification with the following primers: HYB probe reverse, 5′-TCCTTCTGCCAAATCCCGTTATGC-3′, HYB probe forward, 5′-CAAAACTCAAAGTAGAAAGAACAAGG-3′ using 129/svJ mouse genomic DNA as a template. Two correctly targeted ES cell lines were identified from 240 ES cell clones screened.

Injections of targeted ES cells into C57BL/6 blastocysts were performed to generate male chimeras that were mated to C57BL/6 females to test for germline transmission of the Wwoxflox allele. Tail DNA samples from agouti offspring were genotyped by Southern hybridization. Wwox+/flox offspring were then used as the F1 generation for subsequent use. After establishing Mendelian transmission of the Wwoxflox allele genotyping was performed using a multiplex PCR method (Figure 1C,D). The following primers were used for PCR genotyping: Primer A: 5′-ATGGGACGAAACTGGAGCTCAGAA-3′; Primer B: 5′-TCAGCAACTCACTCTGGCTTCAAC-3′; Primer C: 5′-GCATACATTATACGAAGTTATTCGAG-3′.

Generation of Wwox Knockout Mice Using EIIA-Cre Mediated Deletion

Female Wwoxflox/flox mice were bred with male mice homozygous for the Cre-recombinase gene under the control of the adenovirus EIIA-promoter to generate the Wwox+/ΔCre F1 generation. EIIA-Cre transgenic mice [23] were obtained from The Jackson Laboratory (Bar Harbor, ME; stock number: 003724). Genotypes were determined by PCR using the oligonucleotide primers: Primer X: 5′-GCCCCCTTTCCCGCCAGTAGCTG-3′; Primer Y: 5′-GACCCAGATCCCCTAATAACG-3′; Primer Z: 5′-GCCCTCAAGAAGAGGCTGCAATTT-3′.

Western Blot Analysis

Mouse tissues were dissected and flash frozen in liquid nitrogen then crushed into a fine powder with a mortar and pestle. Total protein lysates were made by suspension of crushed tissue with lysis buffer (1% Igepal CA-630, 50 mM Tris-Cl, pH 7.5, 150 mM NaCl, 5 mM EDTA, 10% glycerol) containing protease inhibitors and incubation at 4°C for 30 min. with constant agitation. Insoluble material was then removed by centrifugation at 10,000 x g for 10 min. at 4°C. Protein concentration was determined using the BCA method (Pierce, Rockford, IL). Western blot analysis was performed as previously described [21] using 30 µg of total protein. WWOX protein was detected using a rabbit polyclonal antibody raised against the WWOX WW-domains [24]. The amount of β-actin in each sample was used as an internal control. β-actin was detected using a mouse monoclonal antibody (Sigma Aldrich, St. Louis, MO).

Mouse Necropsy and Histological Analyses

Mice were euthanized by CO2 asphyxiation, organs harvested and immediately weighed using a Mettler AE50 analytical balance.Organs were then fixed in formalin for 24 hours, then 70% ethanol and embedded in paraffin. Tissue sections were stained in H&E or processed for immunostaining. Blood was collected immediately following euthanasia by intracardiac puncture on the left ventricule and allowed to clot at room temperature for 30 minutes. Serum was collected following centrifugation for 10 minutes at 14,000 rpm at 4°C. Blood chemistries were measured using serum from each individual mouse using the Olympus AU400 automated chemistry analyzer. Manual differential and WBC were obtained from feathered blood smears using fresh whole blood from each individual animal.

Bone Analyses

Limbs were dissected and soft tissue was carefully removed then fixed in formalin for 48 hours followed by 70% ethanol. Microcomputed tomography (micro-cT) was performed at the Baylor College of Medicine MicroCT Core facility. Bone histomorphometric analyses were performed at the UT MD Anderson Bone Histomorphometry Core Laboratory (Director, Dr Nora Navone) following the guidelines established by the American Society for Bone and Mineral Research (ASMBR) histomophometry nomenclature committee.


We would like to thank Michael Starbuck, M.S. and the M.D. Anderson Cancer Center bone histomorphometry core for bone histomorphometric analyses, the M.D. Anderson Science Park Histology and Tissue Processing core facility, and the M.D. Anderson Genetically Engineered Mouse Facility.

Author Contributions

Conceived and designed the experiments: JHLM MB CMA. Performed the experiments: JHLM HK JPT DK. Analyzed the data: JHLM DK MB CMA. Wrote the paper: JHLM CMA.


  1. 1. Bednarek AK, Laflin KJ, Daniel RL, Liao Q, Hawkins KA, et al. (2000) WWOX, a novel WW domain-containing protein mapping to human chromosome 16q23.3-24.1, a region frequently affected in breast cancer. Cancer Res 60: 2140–2145.
  2. 2. Ried K, Finnis M, Hobson L, Mangelsdorf M, Dayan S, et al. (2000) Common chromosomal fragile site FRA16D sequence: identification of the FOR gene spanning FRA16D and homozygous deletions and translocation breakpoints in cancer cells. Hum Mol Genet 9: 1651–1663.
  3. 3. Krummel KA, Roberts LR, Kawakami M, Glover TW, Smith DI (2000) The characterization of the common fragile site FRA16D and its involvement in multiple myeloma translocations. Genomics 69: 37–46.
  4. 4. Paige AJ, Taylor KJ, Taylor C, Hillier SG, Farrington S, et al. (2001) WWOX: a candidate tumor suppressor gene involved in multiple tumor types. Proc Natl Acad Sci U S A 98: 11417–11422.
  5. 5. Bednarek AK, Keck-Waggoner CL, Daniel RL, Laflin KJ, Bergsagel PL, et al. (2001) WWOX, the FRA16D Gene, Behaves as a Suppressor of Tumor Growth. Cancer Res 61: 8068–8073.
  6. 6. Aqeilan RI, Croce CM (2007) WWOX in biological control and tumorigenesis. J Cell Physiol 212: 307–310.
  7. 7. Ramos D, Aldaz C (2006) WWOX, a chromosomal fragile site gene and its role in cancer. Adv Exp Med Biol 587: 149–159.
  8. 8. Wu X, Lukacik P, Kavanagh KL, Oppermann U (2007) SDR-type human hydroxysteroid dehydrogenases involved in steroid hormone activation. Mol Cell Endocrinol 265-266: 71–76.
  9. 9. Kallberg Y, Oppermann U, Jornvall H, Persson B (2002) Short-chain dehydrogenase/reductase (SDR) relationships: A large family with eight clusters common to human, animal, and plant genomes. Protein Sci 11: 636–641.
  10. 10. Ludes-Meyers JH, Kil H, Bednarek AK, Drake J, Bedford MT, et al. (2004) WWOX binds the specific proline-rich ligand PPXY: identification of candidate interacting proteins. Oncogene 23: 5049–5055.
  11. 11. Jin C, Ge L, Ding X, Chen Y, Zhu H, et al. (2006) PKA-mediated protein phosphorylation regulates ezrin-WWOX interaction. Biochem Biophys Res Commun 341: 784–791.
  12. 12. Aqeilan RI, Pekarsky Y, Herrero JJ, Palamarchuk A, Letofsky J, et al. (2004) Functional association between Wwox tumor suppressor protein and p73, a p53 homolog. Proc Natl Acad Sci U S A 101: 4401–4406.
  13. 13. Aqeilan RI, Donati V, Palamarchuk A, Trapasso F, Kaou M, et al. (2005) WW domain-containing proteins, WWOX and YAP, compete for interaction with ErbB-4 and modulate its transcriptional function. Cancer Res 65: 6764–6772.
  14. 14. Aqeilan RI, Palamarchuk A, Weigel RJ, Herrero JJ, Pekarsky Y, et al. (2004) Physical and functional interactions between the Wwox tumor suppressor protein and the AP-2gamma transcription factor. Cancer Res 64: 8256–8261.
  15. 15. Matteucci E, Bendinelli P, Desiderio MA (2009) Nuclear localization of active HGF receptor Met in aggressive MDA-MB231 breast carcinoma cells. Carcinogenesis 30: 937–945.
  16. 16. Aqeilan RI, Hassan MQ, de Bruin A, Hagan JP, Volinia S, et al. (2008) The WWOX tumor suppressor is essential for postnatal survival and normal bone metabolism. J Biol Chem 283: 21629–21639.
  17. 17. Fabbri M, Iliopoulos D, Trapasso F, Aqeilan R, Cimmino A, et al. (2005) WWOX gene restoration prevents lung cancer growth in vitro and in vivo. PNAS 102: 15611–15616.
  18. 18. Qin HR, Iliopoulos D, Semba S, Fabbri M, Druck T, et al. (2006) A role for the WWOX gene in prostate cancer. Cancer Res 66: 6477–6481.
  19. 19. Gourley C, Paige AJ, Taylor KJ, Ward C, Kuske B, et al. (2009) WWOX gene expression abolishes ovarian cancer tumorigenicity in vivo and decreases attachment to fibronectin via integrin alpha3. Cancer Res 69: 4835–4842.
  20. 20. Aqeilan R, Trapasso F, Hussain S, Costinean S, Marshall D, et al. (2007) Targeted deletion of Wwox reveals a tumor suppressor function. PNAS 104: 3949–3954.
  21. 21. Ludes-Meyers JH, Kil H, Nunez MI, Conti CJ, Parker-Thornburg J, et al. (2007) WWOX hypomorphic mice display a higher incidence of B-cell lymphomas and develop testicular atrophy. Genes Chromosomes Cancer 46: 1129–1136.
  22. 22. McCarrick JW 3rd, Parnes JR, Seong RH, Solter D, Knowles BB (1993) Positive-negative selection gene targeting with the diphtheria toxin A-chain gene in mouse embryonic stem cells. Transgenic Res 2: 183–190.
  23. 23. Lakso M, Pichel JG, Gorman JR, Sauer B, Okamoto Y, et al. (1996) Efficient in vivo manipulation of mouse genomic sequences at the zygote stage. Proc Natl Acad Sci U S A 93: 5860–5865.
  24. 24. Ludes-Meyers J, Bednarek AK, Popescu NC, Bedford MT, Aldaz CM (2003) WWOX, the Common Chromosomal Fragile Site, FRA16D, Cancer Gene. Cytogenetics and Genome Research Journal 100: 101–110.
  25. 25. Nunez M, Ludes-Meyers J, Aldaz C (2006) WWOX protein expression in normal human tissues. J Mol Hist 37: 115–125.
  26. 26. Suzuki H, Katayama K, Takenaka M, Amakasu K, Saito K, et al. (2009) A spontaneous mutation of the Wwox gene and audiogenic seizures in rats with lethal dwarfism and epilepsy. Genes, Brain and Behavior 8: 650–660.
  27. 27. Suzuki H, Takenaka M, Suzuki K (2007) Phenotypic Characterization of Spontaneously Mutated Rats Showing Lethal Dwarfism and Epilepsy. Comparative Medicine 57: 360–369.
  28. 28. Sun X, Lewandoski M, Meyers EN, Liu YH, Maxson RE Jr, et al. (2000) Conditional inactivation of Fgf4 reveals complexity of signalling during limb bud development. Nat Genet 25: 83–86.